Modafresh: Advanced Wakefulness for Enhanced Cognitive Performance
| Product dosage: 200 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.75 | $52.46 (0%) | 🛒 Add to cart |
| 60 | $1.20 | $104.92 $72.24 (31%) | 🛒 Add to cart |
| 100 | $1.05 | $174.87 $104.92 (40%) | 🛒 Add to cart |
| 200 | $0.81 | $349.73 $162.54 (54%) | 🛒 Add to cart |
| 300 | $0.69 | $524.60 $208.12 (60%) | 🛒 Add to cart |
| 500 | $0.54
Best per pill | $874.33 $268.32 (69%) | 🛒 Add to cart |
Modafresh is a prescription medication specifically formulated to promote wakefulness in individuals experiencing excessive sleepiness due to narcolepsy, obstructive sleep apnea, or shift work sleep disorder. As a non-amphetamine central nervous system stimulant, it offers a targeted mechanism of action that enhances alertness without the typical euphoric effects associated with traditional stimulants. Its unique pharmacological profile makes it a preferred choice among sleep specialists for managing daytime sleepiness while maintaining a favorable safety and tolerability spectrum. Clinical studies demonstrate consistent efficacy in improving wakefulness, cognitive function, and overall quality of life for patients with sleep-wake disorders.
Features
- Active ingredient: Modafinil 100mg or 200mg tablets
- Mechanism: Selective activation of wake-promoting neurons in the hypothalamus
- Formulation: Immediate-release oral tablets
- Half-life: Approximately 15 hours
- Bioavailability: High oral absorption with peak plasma concentration in 2–4 hours
- Metabolism: Hepatic, primarily via CYP3A4 enzyme system
- Excretion: Renal (approximately 80%) and fecal (approximately 10%)
Benefits
- Promotes sustained wakefulness and alertness during waking hours
- Improves cognitive performance including memory, attention, and executive function
- Reduces excessive daytime sleepiness in narcolepsy and related disorders
- Enhances quality of life by enabling normal daily activities and social functioning
- Lower abuse potential compared to traditional stimulants
- Minimal impact on normal sleep architecture when taken as prescribed
Common use
Modafresh is primarily indicated for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea (as adjunct therapy to continuous positive airway pressure), and shift work sleep disorder. Off-label uses may include attention deficit hyperactivity disorder (ADHD), fatigue associated with multiple sclerosis, and cognitive enhancement, though these applications require careful medical supervision and are not FDA-approved indications.
Dosage and direction
The recommended dosage for Modafresh is 200mg taken orally once daily in the morning for narcolepsy and obstructive sleep apnea. For shift work sleep disorder, 200mg should be taken approximately one hour before the start of the work shift. The dosage may be adjusted based on individual response and tolerability, with some patients responding adequately to 100mg daily. Tablets should be swallowed whole with water and may be taken with or without food, though consistent administration with food may reduce the potential for gastrointestinal discomfort.
Precautions
Patients should be monitored for the development of psychiatric symptoms including anxiety, depression, or psychosis. Cardiovascular status should be assessed regularly, particularly in those with pre-existing hypertension or cardiac conditions. Use with caution in patients with history of substance abuse, though the abuse potential is significantly lower than amphetamines. Hepatic impairment requires dosage adjustment, with recommended reduction to 50% of the standard dose in severe liver impairment. Pregnancy and breastfeeding considerations warrant careful risk-benefit assessment under medical supervision.
Contraindications
Modafresh is contraindicated in patients with known hypersensitivity to modafinil or armodafinil. It should not be used in patients with symptomatic cardiovascular disease, including left ventricular hypertrophy, mitral valve prolapse, and recent myocardial infarction. Contraindicated in patients with history of psychosis or severe anxiety disorders. Not recommended for use in patients with severe hepatic impairment without dosage adjustment and close monitoring.
Possible side effects
Common side effects (≥5% incidence) include headache, nausea, nervousness, anxiety, insomnia, dizziness, and diarrhea. Less frequent effects (1-5%) may include dry mouth, decreased appetite, palpitations, and elevated blood pressure. Rare but serious adverse effects (<1%) include Stevens-Johnson syndrome, angioedema, multiorgan hypersensitivity reactions, and psychiatric symptoms including depression, mania, and psychosis. Most side effects are mild to moderate and often diminish with continued therapy.
Drug interaction
Modafresh may reduce the effectiveness of oral contraceptives through induction of CYP3A4 metabolism—alternative contraceptive methods are recommended. It may increase the metabolism of cyclosporine, theophylline, and warfarin, requiring monitoring of drug levels and adjustment. Concurrent use with MAO inhibitors is not recommended due to potential hypertensive crisis. May potentiate effects of other CNS stimulants and sympathomimetic agents. CYP3A4 inhibitors such as ketoconazole may increase modafinil concentrations.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is close to the time for the next scheduled dose. In that case, the missed dose should be skipped to avoid double dosing. Patients should not take two doses at the same time to make up for a missed dose, as this may increase the risk of side effects including insomnia and cardiovascular effects.
Overdose
Symptoms of overdose may include insomnia, central nervous system excitation, agitation, confusion, tachycardia, hypertension, and gastrointestinal distress. In cases of suspected overdose, immediate medical attention should be sought. Treatment is supportive and symptomatic, with monitoring of vital signs and cardiac status. There is no specific antidote for modafinil overdose. Hemodialysis is not expected to enhance elimination due to high protein binding.
Storage
Store at controlled room temperature between 20°C to 25°C (68°F to 77°F). Keep in the original container with the lid tightly closed to protect from moisture and light. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Properly dispose of any unused medication through medication take-back programs or according to FDA guidelines.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Modafresh is available by prescription only and should be used under the supervision of a qualified healthcare professional. Individual results may vary, and not all patients will experience the same benefits or side effects. Always follow your healthcare provider’s instructions regarding dosage and administration.
Reviews
Clinical studies demonstrate that 68% of patients with narcolepsy experience significant improvement in daytime sleepiness with Modafresh therapy. In shift work sleep disorder trials, 74% of patients reported improved alertness during work hours. Patient satisfaction surveys indicate high rates of continued use due to effective wakefulness promotion with manageable side effects. Sleep specialists consistently rate Modafresh as a valuable therapeutic option within the wakefulness-promoting agent class.